Agios Rises on AG-221 News
Agios Pharmaceuticals Inc (NASDAQ:AGIO) has rallied by 25% after the company announced in a regulatory filing that its collaboration partner Celgene Corporation (NASDAQ:CELG) plans to file a new drug application with the FDA for enasidenib (AG-221) by the end of the year. In addition, Celgene will be giving more details on the NDA submission at a biotech conference in Boston today. AG-221 is a first-in-class, oral, selective, potent inhibitor of mutant isocitrate dehydrogenase-2 in relapsed and/or refractory acute myeloid leukemia. 11 funds in our system owned shares of Agios Pharmaceuticals Inc (NASDAQ:AGIO) at the end of the second quarter, down by five funds quarter-over-quarter.
Follow Agios Pharmaceuticals Inc. (NASDAQ:AGIO)
Follow Agios Pharmaceuticals Inc. (NASDAQ:AGIO)
Amazon Expands Restaurant Delivery Service
Amazon.com, Inc. (NASDAQ:AMZN) is in the spotlight today after the everything store announced that it will begin delivering food from restaurants in some parts of London. As with many of Amazon’s extra services, the “Amazon Restaurants” feature is only available for Prime customers. The cost of delivery is free if customers order more than 15 pounds or approximately $20 worth of food. With the feature, Amazon is directly challenging Uber, which recently launched its UberEATS service.
145 hedge funds in our database had a long position in Amazon.com, Inc. (NASDAQ:AMZN) as of the most recent 13F reporting period, up by 12 funds from the previous one.
Follow Amazon Com Inc (NASDAQ:AMZN)
Follow Amazon Com Inc (NASDAQ:AMZN)
Tesla in the Spotlight
Traders are talking about Tesla Motors Inc (NASDAQ:TSLA) today after Bloomberg published an email that Elon Musk wrote to his employees last week. Among the interesting tidbits was the following:
“We are on the razor’s edge of achieving a good Q3, but it requires building and delivering every car we possibly can, while simultaneously trimming any cost that isn’t critical, at least for the next 4.5 weeks. Right now, we are tracking to be a few percentage points negative on cash flow and GAAP profitability, but this is a small number, so I’m confident that we can rally hard and push the results into positive territory.”
There is speculation that Musk is pushing hard for improved third quarter results so that the company can make an equity offering with a boosted stock. Tesla reported in an S4 filing on August 31 that it plans to raise funds by the end of the year. Tesla’s shares are down by over 15% this year and by 9% over the past month, which would likely cause shareholder consternation if an offering were to be made at such a juncture. The number of hedge funds in our system with positions in Tesla Motors Inc (NASDAQ:TSLA) fell by three quarter-over-quarter to 36 at the end of June, ranking it as the second-most popular auto manufacturer.
Follow Tesla Inc. (NASDAQ:TSLA)
Follow Tesla Inc. (NASDAQ:TSLA)
Disclosure: None